Expert review of anticancer therapy
-
Expert Rev Anticancer Ther · Apr 2015
EditorialNew insights into the molecular profile of lung adenocarcinoma and implications for therapy.
Lung cancer is a molecularly heterogeneous disease. The advent of next-generation sequencing techniques has significantly advanced our understanding of the complex molecular underpinnings of lung cancer. ⋯ There is hence an increasing interest in developing a classification system that guides clinical management and also incorporates relevant genomic information. Here, we highlight the molecular features of lung adenocarcinoma as highlighted by several independent groups, and more recently The Cancer Genome Atlas and discuss their potential clinical significance.